With Editas' third CEO in as many years, expect a new CMO and new development partners
Sarepta Therapeutics CMO Gilmore O’Neill will take over as CEO and president of CRISPR biotech Editas Medicine on June 1.
But already in the hours since being announced, O’Neill has been hearing from his network on who could potentially be the new CMO at the gene editing company he’s about to helm. Lisa Michaels was fired from the medical chief post in early February, without public explanation, as part of a rebuilding of the C-suite.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.